Jeuveau

Active Ingredient(s): PrabotulinumtoxinA-xvfs
FDA Approved: * February 1, 2019
Pharm Company: * EVOLUS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Jeuveau Overview

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species.[1] It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. Botulinum is the most acutely lethal toxin known, with an estimated human median lethal...

Read more Jeuveau Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Botulinum_toxin

Recent Jeuveau Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

PrabotulinumtoxinA-xvfs

Injection: 100 Units, 100unit
Vial: 100 units/vial, 100u/vial, 200 units/vial, 50 units/vial

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Jeuveau: (1 result)

Sorted by National Drug Code

72301-595 Jeuveau 100 [Usp'u]/1 Intramuscular Powder by Evolus, Inc.

Other drugs which contain PrabotulinumtoxinA-xvfs or a similar ingredient: (3 results)

BOTOX Botulinum Toxin Type A11 discussions
BOTOX COSMETIC Botulinum Toxin Type A
BOTULINUM TOXIN TYPE A 1 discussion